TrialResults - center - Clinical trials results database in cardiology

GAMMA

You are here: Home > Search and browse > Browse treatment 3

Clinical trials of atorvastatin

Clinical trials of atorvastatin and meta-analysis are available for the following clinical conditions:

acute coronary syndrome

acute coronary syndrome, cholesterol lowering intervention, early initiation

atorvastatin vs placebo : MIRACL, 2001 -
atorvastatin vs pravastatin : PROVE IT - TIMI 22, 2004 -
atorvastatin vs usual care : Colivicchi, 2002 - ESTABLISH, 2004 -

acute myocardial infarction

acute myocardial infarction, cholesterol lowering intervention, all type of patients

atorvastatin high dose vs pravastatin : PROVE-IT, 2004 -

aortic stenosis

aortic stenosis, cholesterol lowering intervention, all type of patients

atorvastatin vs placebo : SALTIRE, 2005 -

atrial fibrillation

atrial fibrillation, prevention, patient with history of atrial fibrillation

atorvastatin vs control : Ozaydin, 2006 -
atorvastatin vs placebo : Dernellis, 2006 - STOP-AF, - Almroth, 2009 - MIRACL (sub-group) (Schwartz), 2004 -

atrial fibrillation, prevention, patients without history of AF (primary prevention)

atorvastatin vs placebo : ARMYDA-3 (AF ancillary study), 2006 - Chello, 2006 - MIRACL (AF ancillary study), 2001 -

CABG surgery

CABG surgery, cholesterol lowering intervention, preoperative statins

preoperative atorvastatin vs placebo : Chello et al., 2006 - Patti et al., 2006 -

cardiovascular prevention

cardiovascular prevention, cholesterol lowering intervention, diabetic patients

atorvastatin high dose vs atorvastatin : TNT (sub group), 2006 -
atorvastatin vs placebo : ASCOT (diabetics sub group), 2003 - CARDS, 2004 - Deutsche Diabetes Dialyse Studie (4D), 2005 - ASPEN, 2006 -

cardiovascular prevention, cholesterol lowering intervention, high risk patients with or without LDL cholesterol elevation

ezetimibe + atorvastatin vs atorvastatin : ZETELD, 2010 -
atorvastatin vs placebo : ASCOT, 2003 -

cardiovascular prevention, cholesterol lowering intervention, patients with prior MI or with CHD

atorvastatin high dose vs atorvastatin : TNT, 2005 -
atorvastatin high dose vs lovastatin : Vascular basis, 2005 -
atorvastatin vs placebo : MIRACL, 2001 -
atorvastatin high dose vs pravastatin : REVERSAL, 2004 - PROVE-IT, 2004 - SAGE, 2007 -
atorvastatin high dose vs simvastatin : IDEAL, 2005 -
atorvastatin vs usual care : GREACE, 2002 -

cardiovascular prevention, cholesterol lowering intervention, patient with related disease

atorvastatin vs placebo : SALTIRE, 2005 -

cardiovascular prevention, cholesterol lowering intervention, all chronical situations

atorvastatin vs angioplasty : AVERT, 1999 -
atorvastatin high dose vs atorvastatin : TNT, 2005 - ZETELD, 2010 -
atorvastatin high dose vs lovastatin : Vascular basis, 2005 -
atorvastatin vs placebo : Mohler III, 2003 - CARDS, 2004 - ASCOT, 2003 - MIRACL, 2001 - SPARCL, 2006 - ASPEN, 2006 - Strey, 2005 -
atorvastatin high dose vs pravastatin : REVERSAL, 2004 - PROVE-IT, 2004 - SAGE, 2007 -
atorvastatin high dose vs simvastatin : IDEAL, 2005 - A to Z, 2004 -
atorvastatin vs usual care : GREACE, 2002 -

cardiovascular prevention, cholesterol lowering intervention, post stroke (or TIA)

atorvastatin vs placebo : SPARCL, 2006 -

cardiovascular prevention, cholesterol lowering intervention, primary prevention

atorvastatin vs placebo : CARDS, 2004 - ASCOT, 2003 - ASPEN, 2006 - Mohler, 2003 - ASPEN (primary prevention sub group), 2006 -

cardiovascular prevention, cholesterol lowering intervention, patients with renal insufficiency (on hemodialysis or transplant)

atorvastatin vs placebo : Deutsche Diabetes Dialyse Studie (4D), 2005 -

diabetes

diabetes, cholesterol lowering intervention, diabetic patients with or withour hypercholesterolemia

atorvastatin high dose vs atorvastatin : TNT (sub group), 2006 -
atorvastatin vs placebo : ASCOT (diabetics sub group), 2003 - ASPEN, 2006 -

heart failure

heart failure, cholesterol lowering intervention, all type of patients

atorvastatin vs control : Wojnicz, 2006 - Yamada, 2007 -
atorvastatin vs placebo : Strey, 2005 - Sola, 2006 -

percutaneous coronary intervention

percutaneous coronary intervention, statin, all type of patients

atorvastatin vs control : NAPLES II (Briguori), 2009 - ESTATE, -
atorvastatin vs placebo : ARMYDA, 2004 - ARMYDA-RECAPTURE, 2009 -
atorvastatin vs usual care : GAIN, 2001 -

peripheral vascular diseases

peripheral vascular diseases, cholesterol lowering intervention, all type of patients

atorvastatin vs placebo : Mohler III, 2003 -

post myocardial infarction

post myocardial infarction, cholesterol lowering intervention, all type of patients

atorvastatin high dose vs atorvastatin : TNT, 2005 -
atorvastatin high dose vs lovastatin : Vascular basis, 2005 -
atorvastatin high dose vs pravastatin : REVERSAL, 2004 - SAGE, 2007 -
atorvastatin high dose vs simvastatin : IDEAL, 2005 -

post stroke

post stroke, cholesterol lowering intervention, all type of patients

atorvastatin vs placebo : SPARCL, 2006 -

Entry terms: CI 981, atorvastatin, CI 981, CI-981, Lipitor, atorvastatin calcium, atorvastatin, calcium salt, amlodipine, atorvastatin drug combination, amlodipine - atorvastatin, Caduet, Pfizer brand of amlodipine, atorvastatin drug combination, 4-hydroxyatorvastatin, 4-hydroxy-atorvastatin, 2-hydroxyatorvastatin, ortho-hydroxyatorvastatin, 2-hydroxy-atorvastatin